The IBEC senior researchers were two of the winners of the fourth edition of the call for applications. Through this initiative, BIST recognises and supports scientist mothers working to reach a leading position and advance the research in their fields.
Last Friday IBEC hosted an exclusive talk with distinguished bestselling author Siddhartha Mukherjee. At the event, which was attended by more than 120 people, Mukherjee presented his latest book “The Harmony of Cells” and shared an interesting talk about the latest advances in advanced therapies with IBEC researchers.
The third edition of the EMBL-IBEC conference organised by the Institute for Bioengineering of Catalonia (IBEC) and the European Molecular Biology Laboratory (EMBL) focused on emerging and advanced therapies, bringing together around 150 international experts in the field of bioengineering last week at the PRBB in Barcelona.
IBEC ICREA Professor Xavier Trepat has been awarded the Lilly Foundation Award in the category of preclinical research. With this accolade, the Fundación Lilly acknowledges Trepat’s work, distinguished by the application of techniques and concepts from physics to the health sciences.
IBEC researcher Pere Roca-Cusachs has been awarded the “ICREA Academia” distinction by the Catalan Institution for Research and Advanced Studies (ICREA). The leader of IBEC’s Cellular and Molecular Mechanobiology group received the award in the Life & Medical Sciences category.
This accreditation, granted by the Ministry of Science, Innovation and Universities, recognizes the relevance and impact of IBEC’s research results internationally and entails funding of 4.5 million euros over 4 years.
Today, on March 14th, the joint ICMS-IBEC symposium took place. This event was co-organized by IBEC and the Institute for Complex Molecular Systems (ICMS). Throughout the conference, researchers from both IBEC and ICMS presented their areas of research, aiming to enhance the scientific collaboration between the two institutions.
Today, the event “Advances in Ataxia Telangiectasia” took place, organized by the Institute of Bioengineering of Catalonia (IBEC) in collaboration with AEFAT, the Spanish ataxia-telangiectasia family association. The gathering brought together patients’ families, researchers, and clinicians to explore the latest advancements in the clinical management of ataxia telangiectasia.
The project focuses on developing a chip that will serve as a model for testing new drugs to treat neuroblastoma, a childhood brain cancer. The research has received €200,000 in funding and is led by Aránzazu Villasante, Senior Researcher at IBEC.
